A new biologic agent for treatment of systemic lupus erythematosus (SLE) being tested in clinical trials is showing promise as a safe and effective new treatment, particularly in patients with more severe disease or serologically active disease. Recently published results of a study that examined the safety and efficacy of atacicept for SLE showed the…
Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data
Plus, rheumatology drug news, safety updates